Email address
[email protected]Contact number
+1 (416) 624-2410Share profile
Band 1
Provided by Eileen M McMahon
Eileen’s market-leading experience, practical advice and industry insight in intellectual property and regulatory law make her a go-to advisor for clients in Canada and the United States.
Chair of Torys’ Intellectual Property and Food and Drug Regulatory practices, Eileen is one of a handful of Canadian lawyers who advise on regulatory clearance and intellectual property protection of products. Across sectors—including life sciences, agribusiness, regenerative medicine and stem cells, cannabis and more—Eileen helps clients identify IP and regulatory assets, obtain and maintain market exclusivity, exploit IP assets and enforce their IP rights.
Eileen is a registered patent and trademark agent in the United States and Canada and is adroit at navigating the issues at play in cross-border matters. She is also a Certified Licensing Professional of the Licensing Executive Society (LES) (2011-2014), United States and Canada. This certification is issued only to persons who have met the requirements for licensing professionals, established by CLP, Inc., under the guidance of the LES. Fewer than 1% of all attorneys have this certification, making Eileen a specialized resource for clients.
Provided by Chambers
Eileen McMahon has cultivated an outstanding reputation in the life sciences sector, with a knowledge base spanning issues from patent filing and prosecution to regulatory compliance and pricing.
Provided by Chambers
Eileen is a leading voice in Canadian pharmaceutical IP. She is a wonderful resource and a pleasure to work with.
Eileen is unmatched in terms of industry experience and insight into the pharmaceutical environment.
She is a great partner and provides value for my team.
Eileen is a leading voice in Canadian pharmaceutical IP. She is a wonderful resource and a pleasure to work with.
Eileen is unmatched in terms of industry experience and insight into the pharmaceutical environment.
She is a great partner and provides value for my team.
1 item provided by Torys LLP
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.